The Hain Celestial Group entered into a Share Purchase Agreement on September 12, 2026, to sell its International business to entities affiliated with AURELIUS for an estimated aggregate gross sale price of £238.5 million (approximately $323.2 million). Net proceeds are expected between $305.0 million and $310.0 million, which will be used to reduce indebtedness. The transaction is conditioned on regulatory approvals and an amendment to the company's credit agreement by October 12, 2026, extending its December 22, 2026 maturity date by at least nine months; failure to secure this extension allows AURELIUS to terminate the deal. Closing is expected in fiscal Q2 ending December 31, 2026. Concurrently, Hain Celestial reported a net loss of $305 million for fiscal year 2026 and total debt of $558 million at quarter-end. The company operates in the health and wellness food industry.